Wockhardt recalls hypertension drug in US

Wockhardt recalls hypertension drug in US

FPJ BureauUpdated: Saturday, June 01, 2019, 12:50 PM IST
article-image

Hyderabad:  Wockhardt Ltd is recalling 109,744 bottles of anti-hypertensive drug belonging to multiple lots from the American market following failure of dissolution test, US regulator FDA said.  According to a notification by the USFDA, the recall is voluntarily and was initiated by the company from April 1 under ‘Class-II’ classification.             The recall of metoprolol is a generic version of AstraZeneca Plc’s branded drug Toprol.

RECENT STORIES

Samsung Unveils AI Studio In Mumbai: Offers Smart Classrooms, AI-Enabled Healthcare

Samsung Unveils AI Studio In Mumbai: Offers Smart Classrooms, AI-Enabled Healthcare

India-US Trade Deal Gets Closer, Trump Gives Positive Signals

India-US Trade Deal Gets Closer, Trump Gives Positive Signals

Airtel Offers Free One-Year Perplexity Pro Subscription To All Users In India: How to Avail

Airtel Offers Free One-Year Perplexity Pro Subscription To All Users In India: How to Avail

Anthem Biosciences IPO Sees Massive 67x Subscription, GMP Soars, Allotment Steps Explained

Anthem Biosciences IPO Sees Massive 67x Subscription, GMP Soars, Allotment Steps Explained

Indian Equity Indices Open Flat As Markets Await Fresh Triggers To Break Out Of Consolidation Phase

Indian Equity Indices Open Flat As Markets Await Fresh Triggers To Break Out Of Consolidation Phase